Phase 3 Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older
- People whose general health and ability to carry out daily activities falls within a certain range, rated on a standard medical scale (confirm with trial site)
- People who have been diagnosed with a type of lung cancer called non-small cell lung cancer (NSCLC), confirmed by laboratory testing of tissue
- People whose lung cancer has a specific genetic change in either the EGFR or ALK gene
- People who have cancer that has spread to the brain tissue, confirmed by imaging scans
- People whose brain metastases are not currently causing symptoms, whether the brain spread was found at the same time as the original cancer or developed later
- People who are willing to sign a consent form and agree to attend follow-up appointments as required by the trial
Who may not be able to join:
- People whose cancer has spread only to the fluid surrounding the brain and spinal cord, without any spread into the brain tissue itself
- People who have cancer that has spread to the brain stem specifically
- People who have previously had radiation therapy to the brain
- People who are not considered suitable for a type of targeted cancer medication called a TKI, as determined by their cancer specialist
- People who are pregnant or currently breastfeeding
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 9122 2417 7000
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Intracranial progression free survival at 24 months
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.